keyword
https://read.qxmd.com/read/38702041/pharmacotherapy-of%C3%A2-chronic-neuropsychiatric-conditions-during-pregnancy
#1
JOURNAL ARTICLE
Sarah M Westberg, Regina Arellano, Nicole E Cieri-Hutcherson, Natalie T Heinrich, Alexandra M Herman, Nicole M Lodise, Sarah McBane, Theresa U Ofili, Niamh O'Grady, Kjersten H Sankey
Many pregnant persons will experience neuropsychiatric conditions during pregnancy, including migraine, attention deficit disorder, depression, and anxiety. Treatment of each of these conditions requires shared decision-making among the individual, family, and health care team. Although medications may include risk, the benefits often outweigh the potential fetal risks. In this article, we review pharmacologic treatment options for each of these conditions and appropriate use in pregnancy to maintain the stability of conditions and to optimize maternal and fetal outcomes...
April 30, 2024: Nursing for Women's Health
https://read.qxmd.com/read/38700250/sequential-administration-of-peripheral-nerve-blocks-and%C3%A2-onabotulinumtoxina-for-the-treatment-of-chronic-migraine-and%C3%A2-other-headache-disorders-a-retrospective-tolerability-and-safety-study
#2
JOURNAL ARTICLE
Christopher C Anderson, Courtney R Iser, Ingrid L Hirte, Sayi Boddu, Marlene E Girardo, Juliana H VanderPluym, Amaal J Starling
OBJECTIVE: To determine the tolerability and safety of concurrent peripheral nerve blocks and onabotulinumtoxinA treatment during a single outpatient clinic procedure visit. BACKGROUND: Procedural interventions are available for the treatment of headache disorders. OnabotulinumtoxinA and peripheral nerve blocks are used as alternatives or in addition to oral therapies to reduce the frequency and intensity of migraine attacks. There is currently a lack of safety data focusing on the sequential administration of local anesthetic via peripheral nerve blocks and onabotulinumtoxinA during a single clinical encounter for the treatment of headache...
May 3, 2024: Headache
https://read.qxmd.com/read/38700185/prevalence-and-burden-of-migraine-in-the-united-states-a-systematic-review
#3
JOURNAL ARTICLE
Fred Cohen, Caroline V Brooks, Daniel Sun, Dawn C Buse, Michael L Reed, Kristina M Fanning, Richard B Lipton
BACKGROUND: This study reviewed migraine prevalence and disability gathered through epidemiologic survey studies in the United States conducted over the past three decades. We summarized these studies and evaluated changing patterns of disease prevalence and disability. METHODS: We conducted a systematic review of US studies addressing the prevalence, disability, and/or burden of migraine, including both episodic migraine (EM) and chronic migraine (CM). A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol was used in conjunction with the PubMed search engine...
May 3, 2024: Headache
https://read.qxmd.com/read/38699683/exploring-the-potential-consortium-of-migraine-and-periodontitis
#4
REVIEW
Deepa Ponnaiyan, Roshan R Rughwani, Ganesh Shetty, Jaideep Mahendra, Dhayanand John Victor, Kaustubh Suresh Thakare, N Sowmya Reddy
OBJECTIVES: Various researches have shown periodontitis to share common pathophysiological pathways with systemic diseases such as diabetes, cardiovascular diseases, and osteoporosis and recently neurological disorders. This article provides a narrative review summarizing the various linking mechanisms and the nature of association between two multifactorial diseases-periodontitis and migraine. MATERIALS AND METHODS: A literature search was performed for articles related to periodontitis and migraine up till the year 2023 which yielded totally 14 articles...
2024: International Journal of Dentistry
https://read.qxmd.com/read/38699286/active-occipital-motion-with-digipressure-as-preoperative-screening-in-migraine-surgery
#5
JOURNAL ARTICLE
Edoardo Raposio, Giorgio Raposio, Ilaria Baldelli, Ziv Peled
BACKGROUND: Modern surgical therapy of chronic headaches/migraines is essentially based on the release/neurolysis of extracranial nerves, which, when compressed or inflamed, act as trigger points and, as such, trigger headache attacks. The aim of this article was to describe a novel maneuver we use as an aid in the preoperative planning of occipital trigger sites. METHODS: In the period of January 2021-September 2023, we operated on 32 patients (11 men, 21 women, age range: 26-68 years), who underwent migraine surgery for occipital trigger point release...
May 2024: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/38694896/multiple-reports-on-the-causal-relationship-between-various-chronic-pain-and-gut-microbiota-a-two-sample-mendelian-randomization-study
#6
JOURNAL ARTICLE
Yuxin Cai, Shuyang Wen, Jinjing Hu, Ziyi Wang, Guozhi Huang, Qing Zeng, Jihua Zou
BACKGROUND: Previous evidence suggests a link between gut microbiota and chronic pain, but the causal relationship is not yet fully understood. METHODS: We categorized gut microbiota based on phylum, class, order, family, and genus levels and gathered pain-related information from the UKB and FinnGen GWAS project. Then, we conducted MR analysis to explore the potential causal relationship between gut microbiota and chronic pain at 12 specific locations. RESULTS: We have discovered a direct connection between genetic susceptibility in the gut microbiota (gut metabolites) and pain experienced at 12 specific locations...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38689942/novel-utilization-of-the-regenerative-peripheral-nerve-interface-technique-after-unsuccessful-nerve-release-for-bilateral-frontal-migraines
#7
Brandon Toliver, Blaire Egan, Payton Sparks, Ashlyn Morris, Ivan Hadad
Regenerative peripheral nerve interface (RPNI) is a surgical technique whose indications include preventing or treating painful neuromas after amputation or peripheral nerve injuries. The procedure involves implanting the distal end of a transected peripheral nerve containing sensory fibers into a selected free muscle graft. Although RPNI procedures have primarily been used after limb amputations, select case reports detail the potential for RPNI to mitigate other sources of neuropathic pain, introducing novel uses to its clinical utility...
April 2024: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/38689684/dry-needling-in-the-management-of-chronic-tension-type-headache-associated-with-levator-scapulae-syndrome-a-case-report
#8
Peter Gagnon, James Dunning, Paul Bliton, Casey Charlebois, Nathan Henry, Patrick Gorby, Firas Mourad
KEY CLINICAL MESSAGE: The use of DN to the muscular trigger points and distal periosteal enthesis of the levator scapulae may be a useful adjunct intervention within a multi-modal plan of care for the management of work-related chronic tension-type headaches associated with LSS. ABSTRACT: Chronic tension-type headaches (CTTH) have a lifetime prevalence of 42% and account for more lost workdays than migraine headaches. Dry needling (DN) is being increasingly used by physical therapists in the management of CTTH; however, to date, the supporting evidence is limited...
May 2024: Clinical Case Reports
https://read.qxmd.com/read/38686331/using-optical-coherence-tomography-and-optical-coherence-tomography-angiography-to-delineate-neurovascular-homeostasis-in-migraine-a-review
#9
REVIEW
Devahuti R Chaliha, Mauro Vaccarezza, Jason Charng, Fred K Chen, Amy Lim, Peter Drummond, Ryusuke Takechi, Virginie Lam, Satvinder S Dhaliwal, John C L Mamo
Migraine is one of the world's most debilitating disorders, and it has recently been shown that changes in the retina can be a potential biomarker for the disease. These changes can be detected by optical coherence tomography (OCT), which measures retinal thickness, and optical coherence tomography angiography (OCTA), which measures vessel density. We searched the databases Google Scholar, ProQuest, Scopus, and Web of Science for studies in English using OCT and OCTA in migraineurs, using the search terms "optical coherence tomography," "OCT," "optical coherence tomography angiography," "OCTA" and "migraine...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38683278/long-term-outcome-after-discontinuation-of-cgrp-targeting-therapy-for-migraine
#10
REVIEW
Soohyun Cho, Byung-Kun Kim
PURPOSE OF REVIEW: Calcitonin gene-related peptide (CGRP)-targeting agents are potential candidates for disease-modifying migraine drugs. However, most studies on CGRP-targeting agents have assessed efficacy outcomes rather than long-term effects after discontinuation. This review aimed to synthesize and scrutinize the latest clinical data on the outcomes after the discontinuation of CGRP-targeting therapy in patients with episodic and chronic migraine, with a particular focus on chronic migraine...
April 29, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38676678/-a-comparative-assessment-of-microbiocenosis-of-saliva-and-oropharynx-in-patients-with-migraine
#11
COMPARATIVE STUDY
I L Naydenova, A B Danilov, A V Simonova, A A Pilipovich, E G Filatova
OBJECTIVE: To identify changes in the microbiome of saliva and to compare it with the microbiome of the oropharynx of patients with migraine. MATERIAL AND METHODS: Sixty patients with migraine (21-56 years old), were examined using a headache diary, MIDAS and VAS. A microbiological examination of saliva and smear from the mucosa of the posterior wall of the oropharynx with evaluation by the method of mass spectrometry of microbial markers (MSMM) with the determination of 57 microorganisms was performed...
2024: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/38674921/l-carnitine-in-the-treatment-of-psychiatric-and-neurological-manifestations-a-systematic-review
#12
REVIEW
Wenbo Wang, Da Pan, Qi Liu, Xiangjun Chen, Shaokang Wang
OBJECTIVE: L-carnitine (LC), a vital nutritional supplement, plays a crucial role in myocardial health and exhibits significant cardioprotective effects. LC, being the principal constituent of clinical-grade supplements, finds extensive application in the recovery and treatment of diverse cardiovascular and cerebrovascular disorders. However, controversies persist regarding the utilization of LC in nervous system diseases, with varying effects observed across numerous mental and neurological disorders...
April 20, 2024: Nutrients
https://read.qxmd.com/read/38674218/headache-in-multiple-sclerosis-a-narrative-review
#13
REVIEW
Bożena Adamczyk, Natalia Morawiec, Sylwia Boczek, Karol Dańda, Mikołaj Herba, Aleksandra Spyra, Agata Sowa, Jarosław Szczygieł, Monika Adamczyk-Sowa
Background : Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system characterized by autoimmune-mediated damage to oligodendrocytes and subsequent myelin destruction. Clinical implications : Clinically, the disease presents with many symptoms, often evolving over time. The insidious onset of MS often manifests with non-specific symptoms (prodromal phase), which may precede a clinical diagnosis by several years. Among them, headache is a prominent early indicator, affecting a significant number of MS patients (50-60%)...
March 30, 2024: Medicina
https://read.qxmd.com/read/38672983/associations-between-chronic-kidney-disease-and-migraine-incidence-findings-from-a-korean-longitudinal-big-data-study
#14
JOURNAL ARTICLE
Mi Jung Kwon, Jwa-Kyung Kim, Min-Jeong Kim, Dae Myoung Yoo, Na-Eun Lee, Kyeong Min Han, Nan Young Kim, Ho Suk Kang, Hyo Geun Choi, Eun Soo Kim
While headaches frequently occur in individuals with chronic kidney disease (CKD), there are few statistical evaluations of their connection to migraines in population-based studies. In this nationwide longitudinal follow-up study of Korean health examination data (2002-2019), a total of 15,443 participants with CKD and 61,772 matched controls were enrolled. We applied overlap-weighted Cox proportional hazard regression models to assess hazard ratios, examining the correlation between CKD and the development of migraines...
March 28, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38668603/reducing-the-impact-of-headache-and-allodynia-score-in-chronic-migraine-an-exploratory-analysis-from-the-real-world-effectiveness-of-anti-cgrp-monoclonal-antibodies-compared-to-onabotulinum-toxin-a-ramo-study
#15
MULTICENTER STUDY
Danilo Antonio Montisano, Riccardo Giossi, Mattia Canella, Claudia Altamura, Marilena Marcosano, Fabrizio Vernieri, Alberto Raggi, Licia Grazzi
BACKGROUND: Chronic migraine (CM) is a disabling and hard-to-treat condition, associated with high disability and high cost. Among the preventive treatments, botulinum toxin A (BoNT-a) and monoclonal antibodies against the calcitonin gene-related protein (anti-CGRP mAbs) are the only disease-specific ones. The assessment of the disease burden is complex, and among others, tools such as the allodynia symptoms checklist (ASC-12) and headache impact test (HIT-6) are very useful. This exploratory study analysed the impact of these two therapies on migraine burden...
April 7, 2024: Toxins
https://read.qxmd.com/read/38666648/effects-of-chronic-pain-diagnoses-on-the-antidepressant-efficacy-of-transcranial-magnetic-stimulation
#16
JOURNAL ARTICLE
Houtan Totonchi Afshar, Joel N Fishbein, Erica J Martinez, Gage M Chu, Mohammad A Shenasa, Dhakshin Ramanathan, Matthew S Herbert
OBJECTIVE: Major depressive disorder (MDD) and chronic pain are highly comorbid and bidirectionally related. Repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex is effective in treating MDD, but additional research is needed to determine if chronic pain interferes with rTMS for MDD. METHODS: Participants were 124 veterans (Mage = 49.14, SD = 13.83) scheduled for 30 sessions of rTMS across six weeks. Depression severity was monitored weekly using the Patient Health Questionnaire-9...
April 26, 2024: Psychosomatic Medicine
https://read.qxmd.com/read/38664605/real-world-effectiveness-and-satisfaction-with-intravenous-eptinezumab-treatment-in-patients-with-chronic-migraine-review-an-observational-multi-site-us-based-study
#17
MULTICENTER STUDY
Charles Argoff, Steven P Herzog, Ryan M Smith, Sameer V Kotak, Liza Sopina, Yvonna Saltarska, Seema Soni-Brahmbhatt, Fawad A Khan
BACKGROUND: Despite recent advancements in migraine treatment, some patients continue to endure significant disease burden. Due to the controlled nature of randomized trials in migraine prevention, many real-world patients with comorbidities or prior exposure to certain therapies are excluded. Capturing evidence of the effectiveness of treatment in real-world clinical settings can further shape treatment paradigms. The objective of this study was to develop a comprehensive understanding of both patients' and physicians' real-world experiences with eptinezumab for chronic migraine (CM)...
April 25, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38663908/candespartan-study-candesartan-spanish-response-prediction-and-tolerability-study-in-migraine
#18
MULTICENTER STUDY
David García-Azorín, Cristina Martínez-Badillo, Javier Camiña Muñiz, Ana Beatriz Gago-Veiga, Noemi Morollón Sánchez, Vicente González-Quintanilla, Jesús Porta-Etessam, Alvaro Sierra-Mencía, Nuria González-García, Yésica González-Osorio, Marcos Polanco-Fernandez, Andrea Recio-García, Robert Belvis Nieto, Angel Luis Guerrero-Peral
INTRODUCTION: Effectiveness of candesartan in migraine prevention is supported by two randomized controlled trials. We aimed to assess the effectiveness, tolerability, and response predictors of candesartan in the preventive treatment of migraine. METHODS: Observational, multicenter, prospective cohort study. The 50%, 75% and 30% responder rates, between weeks 8-12 and 20-24, were compared with the baseline. Treatment emergent adverse effects were systematically evaluated...
April 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38663902/physical-impairment-during-and-between-migraine-attacks-a-daily-diary-study-of-patients-with-chronic-migraine
#19
JOURNAL ARTICLE
David J Whitaker, Gina M Dumkrieger, Joseph G Hentz, David W Dodick, Todd J Schwedt
OBJECTIVE: While a substantial body of research describes the disabling impacts of migraine attacks, less research has described the impacts of migraine on physical functioning between migraine attacks. The objective of this study is to describe physical impairment during and between migraine attacks as a dimension of burden experienced by people living with chronic migraine. METHODS: The physical impairment domain of the Migraine Physical Function Impact Diary was recorded in headache diaries from the Medication Overuse Treatment Strategy trial...
April 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38660947/decreased-cerebral-perfusion-in-chronic-migraine-a-voxel-based-cerebral-blood-flow-analysis-using-3d-pseudo-continuous-arterial-spin-labeling
#20
JOURNAL ARTICLE
Xin Li, Mengqi Liu, Shuqiang Zhao, Zhiye Chen
BACKGROUND: A contrast agent-free approach would be preferable to the frequently used invasive approaches for evaluating cerebral perfusion in chronic migraineurs (CM). In this work, non-invasive quantitative volumetric perfusion imaging was used to evaluate alterations in cerebral perfusion in CM. METHODS: We used conventional brain structural imaging sequences and 3D pseudo-continuous arterial spin labeling (3D PCASL) to examine thirteen CM patients and fifteen normal controls (NCs)...
2024: Current medical imaging
keyword
keyword
103831
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.